Docetaxel in Treating Children With Recurrent Solid Tumors

Completed · Phase 2

Conditions studied: Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma

In brief

Phase II trial to study the effectiveness of docetaxel in treating children with recurrent solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Key facts

Study ID
NCT00002825
Run by
National Cancer Institute (NCI)
People needed
20
Starts
1997-01-01
Last updated by the study team
2013-02-05

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.